Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HouYi: Ticagrelor vs Clopidogrel in Chinese ACS Patients
NCT01864005Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- May 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by AstraZeneca. Started May 2013; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01864005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864005.